Your browser doesn't support javascript.
loading
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
Allu, Prasanna K R; Kiranmayi, Malapaka; Mukherjee, Sromona D; Chirasani, Venkat R; Garg, Richa; Vishnuprabu, Durairajpandian; Ravi, Sudesh; Subramanian, Lakshmi; Sahu, Bhavani S; Iyer, Dhanya R; Maghajothi, Sakthisree; Sharma, Saurabh; Ravi, Marimuthu S; Khullar, Madhu; Munirajan, Arasambattu K; Gayen, Jiaur R; Senapati, Sanjib; Mullasari, Ajit S; Mohan, Viswanathan; Radha, Venkatesan; Naga Prasad, Sathyamangala V; Mahapatra, Nitish R.
Afiliación
  • Allu PKR; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Kiranmayi M; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Mukherjee SD; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Chirasani VR; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Garg R; Pharmaceutics & Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • Vishnuprabu D; Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India.
  • Ravi S; Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India.
  • Subramanian L; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Sahu BS; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Iyer DR; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Maghajothi S; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Sharma S; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Ravi MS; Department of Cardiology, Madras Medical College and Government General Hospital, Chennai, India.
  • Khullar M; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Munirajan AK; Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India.
  • Gayen JR; Pharmaceutics & Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • Senapati S; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
  • Mullasari AS; Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India.
  • Mohan V; Department of Molecular Genetics, Madras Diabetes Research Foundation, Chennai, India.
  • Radha V; Department of Molecular Genetics, Madras Diabetes Research Foundation, Chennai, India.
  • Naga Prasad SV; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Mahapatra NR; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
Diabetes ; 71(3): 538-553, 2022 03 01.
Article en En | MEDLINE | ID: mdl-34862200

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Predisposición Genética a la Enfermedad / Cromogranina A / Enfermedades Metabólicas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Predisposición Genética a la Enfermedad / Cromogranina A / Enfermedades Metabólicas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Año: 2022 Tipo del documento: Article País de afiliación: India